Quick Answer
Zhengye Biotechnology Holding Ltd reported Total Revenue of $186.36 million for fiscal year 2024.
Zhengye Biotechnology Holding Ltd — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Revenue | $186.36M -12.0% |
$211.65M -18.7% |
$260.27M | — |
| Net Income | $11.31M -64.0% |
$31.46M -32.7% |
$46.73M | — |
| Diluted EPS | $0.25 -63.8% |
$0.69 -32.4% |
$1.02 | — |
| Total Assets | $493.25M -1.3% |
$499.89M | — | — |
| Cash and Equivalents | $2.55M -83.1% |
$15.07M | — | — |
| Stockholders Equity | $283.96M +4.1% |
$272.85M -23.5% |
$356.87M +11.9% |
$318.84M |
| R&D Expense | $1.75M -85.3% |
$11.90M -11.3% |
$13.42M | — |
| Operating Income | $16.44M -63.5% |
$44.99M -31.7% |
$65.83M | — |
| Gross Profit | $91.30M -22.3% |
$117.51M -20.5% |
$147.88M | — |
| Shares Outstanding | 45.67M +0.0% |
45.67M | — | — |
- Zhengye Biotechnology Holding Ltd reported Total Revenue of $186.36 million for fiscal year 2024.
- Zhengye Biotechnology Holding Ltd showed a decrease of -12.0% in Total Revenue compared to the prior fiscal year.
- Zhengye Biotechnology Holding Ltd reported Net Income of $11.31 million for fiscal year 2024.
- Zhengye Biotechnology Holding Ltd showed a decrease of -64.0% in Net Income compared to the prior fiscal year.
- Zhengye Biotechnology Holding Ltd reported Diluted EPS of $0.25 per share for fiscal year 2024.
- Zhengye Biotechnology Holding Ltd showed a decrease of -63.8% in Diluted EPS compared to the prior fiscal year.
- Zhengye Biotechnology Holding Ltd reported Total Assets of $493.25 million for fiscal year 2024.
- Zhengye Biotechnology Holding Ltd showed a decrease of -1.3% in Total Assets compared to the prior fiscal year.
- Zhengye Biotechnology Holding Ltd reported Cash and Equivalents of $2.55 million for fiscal year 2024.
- Zhengye Biotechnology Holding Ltd showed a decrease of -83.1% in Cash and Equivalents compared to the prior fiscal year.
- Zhengye Biotechnology Holding Ltd reported Stockholders Equity of $283.96 million for fiscal year 2024.
- Zhengye Biotechnology Holding Ltd showed an increase of +4.1% in Stockholders Equity compared to the prior fiscal year.
- Zhengye Biotechnology Holding Ltd reported R&D Expense of $1.75 million for fiscal year 2024.
- Zhengye Biotechnology Holding Ltd showed a decrease of -85.3% in R&D Expense compared to the prior fiscal year.
- Zhengye Biotechnology Holding Ltd reported Operating Income of $16.44 million for fiscal year 2024.
- Zhengye Biotechnology Holding Ltd showed a decrease of -63.5% in Operating Income compared to the prior fiscal year.
- Zhengye Biotechnology Holding Ltd reported Gross Profit of $91.30 million for fiscal year 2024.
- Zhengye Biotechnology Holding Ltd showed a decrease of -22.3% in Gross Profit compared to the prior fiscal year.
- Zhengye Biotechnology Holding Ltd reported Shares Outstanding of 45.67 million shares for fiscal year 2024.
- Zhengye Biotechnology Holding Ltd showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: